Evidence map›Paper›PMID 38012464›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2024

Two rare autosomal recessive neurological disorders identified by combined genetic approaches in a single consanguineous family with multiple offspring.

Seda Susgun, Emrah Yucesan, Beyza Goncu, Sevde Hasanoglu Sayin, Umit Yasar Kina, Cemil Ozgul, Omer Faruk Duzenli, Ozcan Kocaturk, Mustafa Calik, Ugur Ozbek and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Seda Susgun *Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Vakif Gureba Cad., 34093, Istanbul, Türkiye.ORCID https://orcid.org/0000-0001-9689-3111
Emrah Yucesan *Department of Neurogenetics, Institute of Neurological Sciences, Istanbul University-Cerrahpasa, Istanbul, Türkiye.
Beyza GoncuDepartment of Medical Services and Techniques, Vocational School of Health Sciences, Bezmialem Vakif University, Istanbul, Türkiye.
Sevde Hasanoglu SayinGraduate School of Health Sciences, Istanbul University, Istanbul, Türkiye.
Umit Yasar KinaInstitute of Life Sciences and Biotechnology, Bezmialem Vakif University, Istanbul, Türkiye.
Cemil OzgulRegenerative and Restorative Medicine Research Center (REMER), Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, Türkiye.
Omer Faruk DuzenliDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Vakif Gureba Cad., 34093, Istanbul, Türkiye.
Ozcan KocaturkDepartment of Neurology, Interventional Neurology, Balıkesir Atatürk City Hospital, Balıkesir, Türkiye.
Mustafa CalikDepartment of Pediatric Neurology, Faculty of Medicine, Harran University, Sanliurfa, Türkiye.
Ugur OzbekIBG-Izmir Biomedicine and Genome Center, Izmir, Türkiye.
Sibel Aylin Ugur IseriDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Vakif Gureba Cad., 34093, Istanbul, Türkiye. sibel.ugur@istanbul.edu.tr.ORCID http://orcid.org/0000-0002-5790-6853
Bezmiâlem Vakıf Üniversitesi · TRIstanbul University · TRBalıkesir University · TRHarran University · TRIstanbul Kültür University · TRIstanbul Medipol University · TRIstanbul University-Cerrahpaşa · TRIzmir University · TR

Funding

Bezmialem Vakıf Üniversitesi 12.2019/9Istanbul Üniversitesi 52853Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 113S331Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 2211A
6 · The paper itself

Abstract

introductionNeurodevelopmental disorders (NDDs) refer to a broad range of diseases including developmental delay, intellectual disability, epilepsy, autism spectrum disorders, and attention-deficit/hyperactivity disorder caused by dysfunctions in tightly controlled brain development. The genetic backgrounds of NDDs are quite heterogeneous; to date, recessive or dominant variations in numerous genes have been implicated. Herein, we present a large consanguineous family from Turkiye, who has been suffering from NDDs with two distinct clinical presentations. METHODS AND

resultsCombined in-depth genetic approaches led us to identify a homozygous frameshift variant in NALCN related to NDD and expansion of dodecamer repeat in CSTB related to Unverricht-Lundborg disease (ULD). Additionally, we sought to functionally analyze the NALCN variant in terms of mRNA expression level and current alteration. We have both detected a decrease in the level of premature stop codon-bearing mRNA possibly through nonsense-mediated mRNA decay mechanism and also an increased current in patch-clamp recordings for the expressed truncated protein.

conclusionIn conclusion, increased consanguinity may lead to the revealing of distinct rare neurogenetic diseases in a single family. Exome sequencing is generally considered the first-tier diagnostic test in individuals with NDD. Yet we underline the fact that customized approaches other than exome sequencing may be used as in the case of ULD to aid diagnosis and better genetic counseling.

Indexed as

Intellectual DisabilityNeurodevelopmental DisordersUnverricht-Lundborg SyndromeCodon, NonsenseConsanguinityHumansCodon, NonsenseCSTBExome sequencingLinkage analysisLong PCRNALCNNeurodevelopmental disorders

Identifiers

PMID38012464
OpenAlexW4389069234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.